TSW
AGN

Thompson Siegel & Walmsley’s Allergan plc AGN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,945
Closed -$876K – 724
2020
Q1 		$876K Sell
4,945
-6,733
-58% -$1.27M 0.02% 231
2019
Q4 		$2.23M Sell
11,678
-24,443
-68% -$4.41M 0.03% 203
2019
Q3 		$6.08M Sell
36,121
-1,010,144
-97% -$165M 0.1% 155
2019
Q2 		$175M Buy
1,046,265
+11,904
+1% +$1.65M 2.53% 1
2019
Q1 		$151M Sell
1,034,361
-20,053
-2% -$2.91M 2.12% 1
2018
Q4 		$141M Buy
1,054,414
+54,436
+5% +$8.92M 2.2% 1
2018
Q3 		$190M Buy
999,978
+122,238
+14% +$22.5M 2.43% 1
2018
Q2 		$146M Buy
877,740
+849,719
+3,032% +$136M 1.9% 2
2018
Q1 		$4.72M Sell
28,021
-5,429
-16% -$911K 0.06% 223
2017
Q4 		$5.47M Sell
33,450
-20,490
-38% -$3.68M 0.07% 219
2017
Q3 		$11.1M Buy
53,940
+8,539
+19% +$1.99M 0.13% 177
2017
Q2 		$11M Buy
45,401
+40
+0.1% +$9.4K 0.13% 177
2017
Q1 		$10.8M Buy
45,361
+1,591
+4% +$371K 0.13% 188
2016
Q4 		$9.19M Sell
43,770
-14,585
-25% -$3.02M 0.12% 197
2016
Q3 		$13.4M Buy
58,355
+2,059
+4% +$503K 0.21% 160
2016
Q2 		$13M Buy
56,296
+42,529
+309% +$9.81M 0.21% 155
2016
Q1 		$3.69M Buy
13,767
+10,694
+348% +$3.06M 0.06% 225
2015
Q4 		$960K Buy
3,073
+2,198
+251% +$654K 0.02% 282
2015
Q3 		$238K Hold
875
– – ﹤0.01% 368
2015
Q2 		$266K Sell
875
-73
-8% -$21.8K ﹤0.01% 366
2015
Q1 		$282K Buy
+948
New +$270K ﹤0.01% 367

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Thompson Siegel & Walmsley's AGN Position: Q2 2020 in Review

Thompson Siegel & Walmsley sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,945 shares — an estimated $876K sold.

Thompson Siegel & Walmsley first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $190M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Thompson Siegel & Walmsley reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 4,945 Allergan plc shares in Q2 2020, an estimated $876K.
  • Thompson Siegel & Walmsley first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Thompson Siegel & Walmsley's Allergan plc position peaked at $190M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2020, filed 11 Aug 2020.